Literature DB >> 15014631

National Patterns of Depression Treatment in Primary Care.

Randall S. Stafford1, John C. Ausiello, Bismruta Misra, Demet Saglam.   

Abstract

BACKGROUND: While past studies suggest that primary care physicians underdiagnose and undertreat depression, little is known about recent national patterns of depression treatment.
METHOD: Using the 1995 and 1996 National Ambulatory Medical Care Surveys, we analyzed 1322 primary care office visits by patients reported to have depression. Rates of psychotherapy/mental health counseling, antidepressant use, and benzodiazepine use were assessed. Independent predictors of depression therapy were examined using multiple logistic regression. Where instructive, we compared the practices of primary care physicians with those of psychiatrists (2418 depression visits).
RESULTS: Primary care physicians reported depression in 7.8% of their office visits. For these depression visits, antidepressants (42%) were the most common form of treatment, followed by psychotherapy/mental health counseling (28%) and benzodiazepines (21%). Among specific antidepressants, selective serotonin reuptake inhibitors were most often prescribed by primary care physicians (26% of depression visits). Rates of antidepressant and benzodiazepine use varied significantly by primary care specialty. In addition, geographic region and health insurance status influenced the likelihood of receiving benzodiazepines. In their depression visits, psychiatrists reported psychotherapy/mental health counseling (88%) most frequently, followed by antidepressants (64%) and benzodiazepines (25%).
CONCLUSION: The predominant use of selective serotonin reuptake inhibitors suggests that primary care physicians have begun to adopt new therapeutic strategies for depression. The modest rate of antidepressant therapy for a clinical population specifically identified by primary care physicians as having depression may indicate undertreatment of depression in primary care settings. Furthermore, high rates of benzodiazepine use are inconsistent with treatment guidelines, and variations in treatment patterns suggest that nonclinical factors influence depression management.

Entities:  

Year:  2000        PMID: 15014631      PMCID: PMC181143          DOI: 10.4088/pcc.v02n0603

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  24 in total

1.  HMO physicians' use of referrals.

Authors:  K H Bachman; D K Freeborn
Journal:  Soc Sci Med       Date:  1999-02       Impact factor: 4.634

Review 2.  An agenda for primary care psychiatry.

Authors:  L R Wulsin
Journal:  Psychosomatics       Date:  1996 Mar-Apr       Impact factor: 2.386

Review 3.  Major depression: assessing the role of new antidepressants.

Authors:  B T Vanderhoff; K E Miller
Journal:  Am Fam Physician       Date:  1997-01       Impact factor: 3.292

4.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

5.  Recognition and treatment of depressive disorders by internal medicine attendings and housestaff.

Authors:  J V Penn; R Boland; J R McCartney; R Kohn; T Mulvey
Journal:  Gen Hosp Psychiatry       Date:  1997-05       Impact factor: 3.238

6.  Benzodiazepines in depressive disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Arch Gen Psychiatry       Date:  1978-11

7.  Referrals by general internists and internal medicine trainees in an academic medicine practice.

Authors:  S J Borowsky; L V Rubenstein; S A Skootsky; M F Shapiro
Journal:  Am J Manag Care       Date:  1997-11       Impact factor: 2.229

8.  Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program.

Authors:  W E Narrow; D A Regier; D S Rae; R W Manderscheid; B Z Locke
Journal:  Arch Gen Psychiatry       Date:  1993-02

9.  The treatment of depression: prescribing practices of primary care physicians and psychiatrists.

Authors:  M Olfson; G L Klerman
Journal:  J Fam Pract       Date:  1992-12       Impact factor: 0.493

10.  Health care costs associated with depressive and anxiety disorders in primary care.

Authors:  G Simon; J Ormel; M VonKorff; W Barlow
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

View more
  23 in total

1.  Major depressive disorder and medical illness: STAR*D outcomes.

Authors:  Prakash Masand; Meera Narasimhan
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

2.  Correlates of depressive symptoms among women seeking cancer genetic counseling and risk assessment at a high-risk cancer clinic.

Authors:  Molly Middlecamp Kodl; Judith W Lee; Alicia K Matthews; Shelly A Cummings; Olufunmilayo I Olopade
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

3.  Pilot Randomized Trial of a Self-Help Behavioral Activation Mobile App for Utilization in Primary Care.

Authors:  Jennifer Dahne; C W Lejuez; Vanessa A Diaz; Marty S Player; Jacob Kustanowitz; Julia W Felton; Matthew J Carpenter
Journal:  Behav Ther       Date:  2018-12-19

4.  Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.

Authors:  Bradley N Gaynes; Joanne DeVeaugh-Geiss; Sam Weir; Hongbin Gu; Cora MacPherson; Herbert C Schulberg; Larry Culpepper; David R Rubinow
Journal:  Ann Fam Med       Date:  2010 Mar-Apr       Impact factor: 5.166

Review 5.  Strategies to improve the management of depression in primary care.

Authors:  Jürgen Unützer; Mijung Park
Journal:  Prim Care       Date:  2012-06       Impact factor: 2.907

6.  Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation.

Authors:  Stephen E Gilman; Garrett M Fitzmaurice; Martha L Bruce; Thomas Ten Have; M Maria Glymour; Hannah Carliner; George S Alexopoulos; Benoit H Mulsant; Charles F Reynolds; Alex Cohen
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

7.  Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting.

Authors:  Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb
Journal:  Popul Health Manag       Date:  2017-12-06       Impact factor: 2.459

8.  Religiosity, spirituality, and psychological distress in African-Americans at risk for having a hereditary cancer predisposing gene mutation.

Authors:  Anita Y Kinney; James E Coxworth; Sara E Simonson; Joseph B Fanning
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-02-15       Impact factor: 3.908

9.  Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials.

Authors:  David L Dunner; Kimberly K Laubmeier; George Manos; Robert A Forbes; Ross A Baker; Robert M Berman
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-22

10.  Metamemory without the memory: are people aware of midazolam-induced amnesia?

Authors:  Paul Merritt; Elliot Hirshman; John Hsu; Michael Berrigan
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.